Alimentary Pharmacology & Therapeutics, 51(9), 880-888. Wiley Alimentary Pharmacology & Therapeutics, 51, 9, pp. 880-888 Alimentary Pharmacology and Therapeutics, 51(9), 880-888 Alimentary Pharmacology and Therapeutics, 51(9), 880-888. Wiley-Blackwell Publishing Ltd Alimentary Pharmacology & Therapeutics Alimentary pharmacology & therapeutics, 51(9), 880-888. Wiley-Blackwell Biemans, V B C, Sleutjes, J A M, de Vries, A C, Bodelier, A G L, Dijkstra, G, Oldenburg, B, Löwenberg, M, van Bodegraven, A A, van der Meulen-de Jong, A E, de Boer, N K H, Srivastava, N, West, R L, Römkens, T E H, Horjus Talabur Horje, C S, Jansen, J M, van der Woude, C J, Hoekstra, J, Weersma, R K, van Schaik, F D M, Hoentjen, F, Pierik, M J & the Dutch Initiative on Crohn and Colitis (ICC) 2020, ' Tofacitinib for ulcerative colitis : results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry ', Alimentary Pharmacology and Therapeutics, vol. 51, no. 9, pp. 880-888 . https://doi.org/10.1111/apt.15689 Alimentary Pharmacology & Therapeutics, 51, 880-888 Alimentary Pharmacology and Therapeutics, 51(9), 880-888. WILEY